AbbVie's growth thrives on strong earnings, a robust immunology portfolio, and diversification. See why ABBV stock is a ...
The GAO found it takes 11 years from an initial idea to delivery for many of the DOD's major acquisitions programs.
Through Aerospace & Defense Insights, we share with you the top legal and political issues affecting the aerospace and defense (A&D) industry.
Getting the right technology and data is imperative for driving DoD transformation initiatives, says Maximus’ Bryan Martz.